Upcoming events

Apr 2017

2017-04-01 00:00:00.000000
7-9 Apr 2017
PCR Tokyo Valves 2017



May 2017

2017-05-01 00:00:00.000000
16-19 May 2017
EuroPCR 2017



A new global strategy for 3-vessel disease from SYNTAX II: iFR/FFR and IVUS-guided PCR and new-generation DES


The early, 30-day outcomes, from the SYNTAX II trial are in and P. Serruys is here to challenge us with these early results. How do we “open the dialogue” on this new global strategy for treating three-vessel disease? What are the questions we need to ask both surgeon and patient? What is the role of imaging? Of iFR/FFR assessment, of IVUS-guided percutaneous coronary revascularisation?  And what about newer-generation DES?

Let P. Serruys lead us through, step-by-step…